Efficacy, Safety, and Economic Impact of a Basal Insulin Titration App, My Dose Coach™, in People with Type 2 Diabetes Mellitus in Mexico

Diabetes Technology and Obesity Medicine 2026 Open access

Read full text
Authors: Miguel A. Polanco-Preza, J.R. Barrientos-Ávalos, Salvador Plascencia-Pérez, Luis Anguiano, María Elena Sañudo‐Maury
DOI: 10.1177/29986702251414137
Cited by: 0
References: 20

Abstract

Introduction: My Dose Coach™ (MDC) is a U.S. Food and Drug Administration-approved digital smartphone application designed to help users with type 2 diabetes mellitus (T2DM) to titrate their basal insulin (BI) according to a clinician-prescribed individualized titration plan. The present analysis aimed to compare the efficacy of the MDC app in achieving the fasting plasma glucose (FPG) target, glycemic goals (glycated hemoglobin [HbA1c]

Fields of Study & Subjects

Diabetes Management and Research Diabetes Treatment and Management Mobile Health and mHealth Applications

Publication details

Journal / source
Diabetes Technology and Obesity Medicine
Volume
2
Publication date
1 January 2026
Language
EN